TY - JOUR AU - Chen, C. D. AU - Welsbie, D. S. AU - Tran, C. AU - Baek, S. H. AU - Chen, R. AU - Vessella, R. AU - Rosenfeld, M. G. AU - Sawyers, C. L. PY - 2004 DA - 2004// TI - Molecular determinants of resistance to antiandrogen therapy JO - Nat Med VL - 10 UR - https://doi.org/10.1038/nm972 DO - 10.1038/nm972 ID - Chen2004 ER - TY - JOUR AU - Kinkade, C. W. AU - Castillo-Martin, M. AU - Puzio-Kuter, A. PY - 2008 DA - 2008// TI - Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model JO - J Clin Invest VL - 118 ID - Kinkade2008 ER - TY - JOUR AU - Bernier, J. AU - Hall, E. J. AU - Giaccia, A. PY - 2004 DA - 2004// TI - Radiation oncology: a century of achievements JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1451 DO - 10.1038/nrc1451 ID - Bernier2004 ER - TY - JOUR AU - Rodemann, H. P. AU - Blaese, M. A. PY - 2007 DA - 2007// TI - Responses of normal cells to ionizing radiation JO - Semin Radiat Oncol VL - 17 UR - https://doi.org/10.1016/j.semradonc.2006.11.005 DO - 10.1016/j.semradonc.2006.11.005 ID - Rodemann2007 ER - TY - JOUR AU - Grivennikov, S. I. AU - Greten, F. R. AU - Karin, M. PY - 2010 DA - 2010// TI - Immunity, inflammation, and cancer JO - Cell VL - 140 UR - https://doi.org/10.1016/j.cell.2010.01.025 DO - 10.1016/j.cell.2010.01.025 ID - Grivennikov2010 ER - TY - JOUR AU - Deorukhkar, A. AU - Krishnan, S. PY - 2010 DA - 2010// TI - Targeting inflammatory pathways for tumor radiosensitization JO - Biochem Pharmacol VL - 80 UR - https://doi.org/10.1016/j.bcp.2010.06.039 DO - 10.1016/j.bcp.2010.06.039 ID - Deorukhkar2010 ER - TY - JOUR AU - Kishimoto, T. PY - 2005 DA - 2005// TI - Interleukin-6: from basic science to medicine–40 years in immunology JO - Annu Rev Immunol VL - 23 UR - https://doi.org/10.1146/annurev.immunol.23.021704.115806 DO - 10.1146/annurev.immunol.23.021704.115806 ID - Kishimoto2005 ER - TY - JOUR AU - Malinowska, K. AU - Neuwirt, H. AU - Cavarretta, I. T. PY - 2009 DA - 2009// TI - Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor JO - Endocr Relat Cancer VL - 16 UR - https://doi.org/10.1677/ERC-08-0174 DO - 10.1677/ERC-08-0174 ID - Malinowska2009 ER - TY - JOUR AU - Bonner, J. A. AU - Trummell, H. Q. AU - Willey, C. D. AU - Plants, B. A. AU - Raisch, K. P. PY - 2009 DA - 2009// TI - Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma JO - Radiother Oncol VL - 92 UR - https://doi.org/10.1016/j.radonc.2009.06.022 DO - 10.1016/j.radonc.2009.06.022 ID - Bonner2009 ER - TY - JOUR AU - Hong, D. S. AU - Angelo, L. S. AU - Kurzrock, R. PY - 2007 DA - 2007// TI - Interleukin-6 and its receptor in cancer: implications for translational therapeutics JO - Cancer VL - 110 UR - https://doi.org/10.1002/cncr.22999 DO - 10.1002/cncr.22999 ID - Hong2007 ER - TY - JOUR AU - Schafer, Z. T. AU - Brugge, J. S. PY - 2007 DA - 2007// TI - IL-6 involvement in epithelial cancers JO - J Clin Invest VL - 117 UR - https://doi.org/10.1172/JCI34237 DO - 10.1172/JCI34237 ID - Schafer2007 ER - TY - JOUR AU - Culig, Z. AU - Puhr, M. PY - 2012 DA - 2012// TI - Interleukin-6: a multifunctional targetable cytokine in human prostate cancer JO - Mol Cell Endocrinol VL - 360 UR - https://doi.org/10.1016/j.mce.2011.05.033 DO - 10.1016/j.mce.2011.05.033 ID - Culig2012 ER - TY - JOUR AU - Guo, Y. AU - Xu, F. AU - Lu, T. AU - Duan, Z. AU - Zhang, Z. PY - 2012 DA - 2012// TI - Interleukin-6 signaling pathway in targeted therapy for cancer JO - Cancer Treat Rev VL - 38 UR - https://doi.org/10.1016/j.ctrv.2012.04.007 DO - 10.1016/j.ctrv.2012.04.007 ID - Guo2012 ER - TY - JOUR AU - Plante, M. AU - Rubin, S. C. AU - Wong, G. Y. AU - Federici, M. G. AU - Finstad, C. L. AU - Gastl, G. A. PY - 1994 DA - 1994// TI - Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer JO - Cancer VL - 73 UR - https://doi.org/3.0.CO;2-R DO - 3.0.CO;2-R ID - Plante1994 ER - TY - JOUR AU - Zhang, G. J. AU - Adachi, I. PY - 1999 DA - 1999// TI - Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma JO - Anticancer Res VL - 19 ID - Zhang1999 ER - TY - JOUR AU - Chen, M. F. AU - Chen, P. T. AU - Lu, M. S. AU - Lin, P. Y. AU - Chen, W. C. AU - Lee, K. D. PY - 2013 DA - 2013// TI - IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus JO - Mol Cancer VL - 12 UR - https://doi.org/10.1186/1476-4598-12-26 DO - 10.1186/1476-4598-12-26 ID - Chen2013 ER - TY - JOUR AU - Gabrilovich, D. I. AU - Nagaraj, S. PY - 2009 DA - 2009// TI - Myeloid-derived suppressor cells as regulators of the immune system JO - Nat Rev Immunol VL - 9 UR - https://doi.org/10.1038/nri2506 DO - 10.1038/nri2506 ID - Gabrilovich2009 ER - TY - JOUR AU - Kozin, S. V. AU - Kamoun, W. S. AU - Huang, Y. AU - Dawson, M. R. AU - Jain, R. K. AU - Duda, D. G. PY - 2010 DA - 2010// TI - Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-4446 DO - 10.1158/0008-5472.CAN-09-4446 ID - Kozin2010 ER - TY - JOUR AU - Wu, C. T. AU - Hsieh, C. C. AU - Lin, C. C. AU - Chen, W. C. AU - Hong, J. H. AU - Chen, M. F. PY - 2012 DA - 2012// TI - Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells JO - J Mol Med (Berl) VL - 90 UR - https://doi.org/10.1007/s00109-012-0916-x DO - 10.1007/s00109-012-0916-x ID - Wu2012 ER - TY - JOUR AU - Chen, M. F. AU - Chen, W. C. AU - Chang, Y. J. AU - Wu, C. F. AU - Wu, C. T. PY - 2010 DA - 2010// TI - Role of DNA methyltransferase 1 in hormone-resistant prostate cancer JO - J Mol Med (Berl) VL - 88 UR - https://doi.org/10.1007/s00109-010-0640-3 DO - 10.1007/s00109-010-0640-3 ID - Chen2010 ER - TY - JOUR AU - Wu, C. T. AU - Chen, W. C. AU - Liao, S. K. AU - Hsu, C. L. AU - Lee, K. D. AU - Chen, M. F. PY - 2007 DA - 2007// TI - The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy JO - Endocr Relat Cancer VL - 14 UR - https://doi.org/10.1677/ERC-07-0073 DO - 10.1677/ERC-07-0073 ID - Wu2007 ER - TY - JOUR AU - Chen, M. F. AU - Hsieh, C. C. AU - Chen, W. C. AU - Lai, C. H. PY - 2012 DA - 2012// TI - Role of interleukin-6 in the radiation response of liver tumors JO - Int J Radiat Oncol Biol Phys VL - 84 UR - https://doi.org/10.1016/j.ijrobp.2012.07.2360 DO - 10.1016/j.ijrobp.2012.07.2360 ID - Chen2012 ER - TY - JOUR AU - Youn, J. I. AU - Nagaraj, S. AU - Collazo, M. AU - Gabrilovich, D. I. PY - 2008 DA - 2008// TI - Subsets of myeloid-derived suppressor cells in tumor-bearing mice JO - J Immunol VL - 181 UR - https://doi.org/10.4049/jimmunol.181.8.5791 DO - 10.4049/jimmunol.181.8.5791 ID - Youn2008 ER - TY - JOUR AU - Li, H. AU - Han, Y. AU - Guo, Q. AU - Zhang, M. AU - Cao, X. PY - 2009 DA - 2009// TI - Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1 JO - J Immunol VL - 182 UR - https://doi.org/10.4049/jimmunol.182.1.240 DO - 10.4049/jimmunol.182.1.240 ID - Li2009 ER - TY - JOUR AU - Myhre, O. AU - Andersen, J. M. AU - Aarnes, H. AU - Fonnum, F. PY - 2003 DA - 2003// TI - Evaluation of the probes 2’,7’-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation JO - Biochem Pharmacol VL - 65 UR - https://doi.org/10.1016/S0006-2952(03)00083-2 DO - 10.1016/S0006-2952(03)00083-2 ID - Myhre2003 ER - TY - JOUR AU - Sharma, S. AU - Sharma, M. C. AU - Sarkar, C. PY - 2005 DA - 2005// TI - Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis JO - Histopathology VL - 46 UR - https://doi.org/10.1111/j.1365-2559.2005.02142.x DO - 10.1111/j.1365-2559.2005.02142.x ID - Sharma2005 ER - TY - JOUR AU - Tulard, A. AU - Hoffschir, F. AU - de Boisferon, F. H. AU - Luccioni, C. AU - Bravard, A. PY - 2003 DA - 2003// TI - Persistent oxidative stress after ionizing radiation is involved in inherited radiosensitivity JO - Free Radic Biol Med VL - 35 UR - https://doi.org/10.1016/S0891-5849(03)00243-0 DO - 10.1016/S0891-5849(03)00243-0 ID - Tulard2003 ER - TY - JOUR AU - Wallner, L. AU - Dai, J. AU - Escara-Wilke, J. PY - 2006 DA - 2006// TI - Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-3447 DO - 10.1158/0008-5472.CAN-05-3447 ID - Wallner2006 ER - TY - JOUR AU - Fizazi, K. AU - De Bono, J. S. AU - Flechon, A. PY - 2012 DA - 2012// TI - Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer JO - Eur J Cancer VL - 48 UR - https://doi.org/10.1016/j.ejca.2011.10.014 DO - 10.1016/j.ejca.2011.10.014 ID - Fizazi2012 ER - TY - JOUR AU - Trikha, M. AU - Corringham, R. AU - Klein, B. AU - Rossi, J. F. PY - 2003 DA - 2003// TI - Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence JO - Clin Cancer Res VL - 9 ID - Trikha2003 ER - TY - JOUR AU - Leu, C. M. AU - Wong, F. H. AU - Chang, C. AU - Huang, S. F. AU - Hu, C. P. PY - 2003 DA - 2003// TI - Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1207084 DO - 10.1038/sj.onc.1207084 ID - Leu2003 ER - TY - JOUR AU - Lowndes, N. F. AU - Murguia, J. R. PY - 2000 DA - 2000// TI - Sensing and responding to DNA damage JO - Curr Opin Genet Dev VL - 10 UR - https://doi.org/10.1016/S0959-437X(99)00050-7 DO - 10.1016/S0959-437X(99)00050-7 ID - Lowndes2000 ER - TY - JOUR AU - Achanta, G. AU - Huang, P. PY - 2004 DA - 2004// TI - Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-04-0494 DO - 10.1158/0008-5472.CAN-04-0494 ID - Achanta2004 ER - TY - JOUR AU - Colombel, M. AU - Radvanyi, F. AU - Blanche, M. PY - 1999 DA - 1999// TI - Androgen suppressed apoptosis is modified in p53 deficient mice JO - Oncogene VL - 10 ID - Colombel1999 ER - TY - JOUR AU - Burchardt, M. AU - Burchardt, T. AU - Shabsigh, A. PY - 2001 DA - 2001// TI - Reduction of wild type p53 function confers a hormone resistant phenotype on LNCaP prostate cancer cells JO - Prostate VL - 48 UR - https://doi.org/10.1002/pros.1101 DO - 10.1002/pros.1101 ID - Burchardt2001 ER - TY - JOUR AU - Niu, G. AU - Wright, K. L. AU - Ma, Y. PY - 2005 DA - 2005// TI - Role of Stat3 in regulating p53 expression and function JO - Mol Cell Biol VL - 25 UR - https://doi.org/10.1128/MCB.25.17.7432-7440.2005 DO - 10.1128/MCB.25.17.7432-7440.2005 ID - Niu2005 ER - TY - JOUR AU - Sun, Y. AU - Nelson, P. S. PY - 2012 DA - 2012// TI - Molecular pathways: involving microenvironment damage responses in cancer therapy resistance JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-0768 DO - 10.1158/1078-0432.CCR-11-0768 ID - Sun2012 ER - TY - JOUR AU - Lee, S. O. AU - Lou, W. AU - Hou, M. AU - de Miguel, F. AU - Gerber, L. AU - Gao, A. C. PY - 2003 DA - 2003// TI - Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells JO - Clin Cancer Res VL - 9 ID - Lee2003 ER - TY - JOUR AU - Steiner, H. AU - Berger, A. P. AU - Godoy-Tundidor, S. PY - 2004 DA - 2004// TI - An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6 JO - Eur J Cancer VL - 40 UR - https://doi.org/10.1016/j.ejca.2003.11.033 DO - 10.1016/j.ejca.2003.11.033 ID - Steiner2004 ER - TY - JOUR AU - Yang, L. AU - DeBusk, L. M. AU - Fukuda, K. PY - 2004 DA - 2004// TI - Expansion of myeloid immune suppressor Gr + CD11b + cells in tumor-bearing host directly promotes tumor angiogenesis JO - Cancer Cell VL - 6 UR - https://doi.org/10.1016/j.ccr.2004.08.031 DO - 10.1016/j.ccr.2004.08.031 ID - Yang2004 ER -